Authors :
Dr. Sejal Parati; Dr Madhav Prabhu
Volume/Issue :
Volume 10 - 2025, Issue 2 - February
Google Scholar :
https://tinyurl.com/5n8veh22
Scribd :
https://tinyurl.com/392fc5hv
DOI :
https://doi.org/10.5281/zenodo.14979562
Abstract :
Guillain-Barré Syndrome (GBS) is an acute, immune-mediated polyradiculoneuropathy characterized by
rapidly progressive weakness and areflexia. This case report presents a 24- year-old male diagnosed with GBS, outlining
his initial presentation, diagnosis, treatment course, and recovery. Early recognition and timely intervention with
intravenous immunoglobulin (IVIG) resulted in favorable outcomes, emphasizing the importance ofdiagnosis and
management in GBS cases.
References :
- Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388(10045):717-727.
- van Doorn PA. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS). Presse Med. 2013;42(6 Pt 2):e193-e201.
- Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366(9497):1653-1666.
Guillain-Barré Syndrome (GBS) is an acute, immune-mediated polyradiculoneuropathy characterized by
rapidly progressive weakness and areflexia. This case report presents a 24- year-old male diagnosed with GBS, outlining
his initial presentation, diagnosis, treatment course, and recovery. Early recognition and timely intervention with
intravenous immunoglobulin (IVIG) resulted in favorable outcomes, emphasizing the importance ofdiagnosis and
management in GBS cases.